HCV J6/JFH1 Tilts the Capability of Myeloid-Derived Dendritic Cells to Favor the Induction of Immunosuppression and Th17-Related Inflammatory Cytokines
参考文献:1. Hahn YS. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? Curr Opin Immunol. 2003;15:443鈥?. CrossRef 2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558鈥?7. CrossRef 3. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946鈥?2. CrossRef 4. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, / et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578鈥?2. CrossRef 5. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395鈥?06. CrossRef 6. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, / et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995;346:1006鈥?. CrossRef 7. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, / et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology. 1999;117:933鈥?1. CrossRef 8. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, / et al. HCV persistence and immune evasion in the absence of memory T cell help. Science. 2003;302:659鈥?2. CrossRef 9. Shoukry NH, Cawthon AG, Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol. 2004;58:391鈥?24. CrossRef 10. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245鈥?2. CrossRef 11. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol. 2007;19:48鈥?5. CrossRef 12. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984鈥?3. CrossRef 13. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445鈥?9. CrossRef 14. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621鈥?3. CrossRef 15. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, / et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584鈥?1. 16. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 2001;120:512鈥?4. CrossRef 17. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97:3171鈥?. CrossRef 18. Pachiadakis I, Pollara G, Chain BM, Naoumov NV. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? Lancet Infect Dis. 2005;5:296鈥?04. CrossRef 19. Waggoner SN, Hall CH, Hahn YS. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol. 2007;82:1407鈥?9. CrossRef 20. Zimmermann M, Flechsig C, La Monica N, Tripodi M, Adler G, Dikopoulos N. Hepatitis C virus core protein impairs / in vitro priming of specific T cell responses by dendritic cells and hepatocytes. J Hepatol. 2008;48:51鈥?0. CrossRef 21. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem. 2004;279:43479鈥?6. CrossRef 22. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics Jr L, / et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170:5615鈥?4. CrossRef 23. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, / et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol. 2004;78:8322鈥?2. CrossRef 24. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, / et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem. 2003;278:20358鈥?6. CrossRef 25. Liang H, Russell RS, Yonkers NL, McDonald D, Rodriguez B, Harding CV, / et al. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol. 2009;83:5693鈥?07. CrossRef 26. Shiina M, Rehermann B. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology. 2008;47:385鈥?5. CrossRef 27. Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol. 2012;24:97鈥?06. CrossRef 28. Repnik U, Knezevic M, Jeras M. Simple and cost-effective isolation of monocytes from Buffy coats. J Immunol Methods. 2003;278:283鈥?2. CrossRef 29. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T. Cell culture and infection system for hepatitis C virus. Nat Protoc. 2006;1:2334鈥?. CrossRef 30. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, / et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623鈥?. CrossRef 31. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693鈥?33. CrossRef 32. Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, / et al. Characterization of HCV-specific CD4 + Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant. 2011;11:775鈥?5. CrossRef 33. Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR. Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection. Dig Dis Sci. 2012;57:381鈥?. CrossRef 34. Grafmueller S, Billerbeck E, Blum HE, Neumann-Haefelin C, Thimme R. Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon gamma-producing CD8(+) T cells during chronic infection. J Infect Dis. 2012;205:1142鈥?. CrossRef 35. Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation. 2011;92:1364鈥?0. CrossRef 36. Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012;27:273鈥?. CrossRef 37. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, Cleary PP, / et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol. 2010;11:83鈥?. CrossRef 38. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997;159:4772鈥?0.
刊物类别:Biomedical and Life Sciences
刊物主题:Biomedicine Pharmacology and Toxicology Pharmacy Biochemistry Medical Law Biomedical Engineering